NIDDK Funding Opportunity

U01 Research Project Cooperative Agreement

Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) (U01)

The purpose of this Funding Opportunity Announcement (FOA) is to establish the second phase of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) through a cooperative agreement. The CKD BioCon was established as a cooperative agreement in September 2009 as a result of RFA-DK-08-015  [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to discover, develop, validate and qualify biomarkers based on existing stored or reposited biosamples from well-characterized CKD patients with longitudinal follow-up. The current CKD BioCon consists of six Participating Centers (PCs) and is actively engaged in multiple research protocols. The next phase of the CKD BioCon will continue a multicenter consortium to identify new biomarkers or rigorously validate already identified biomarkers for chronic kidney diseases, consisting of successful applicants to this FOA.  Application for the second phase of the CKD BioCon will be open to members of the original consortium as well as new investigative teams.  ​

Full AnnouncementRFA-DK-14-011
Notice(s) for this Opportunity


Open Date11/2/2014
Letter of Intent Due Date

November 2, 2014​

Application Due Date
December 2, 2014, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.​
NIDDK Program ContactPaul Kimmel, M.D.

Print Page

Click outside of the light box to close the box.